🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the safety and efficacy of the combination of eftilagimod alpha wi...
Status
Completed
Location
Oncology Consultants
Start Date
2019-02-21
Trial ID
NCT03625323
Treatments Being Tested
Evaluate the safety and efficacy of eftilagimod alpha in combination with p...
Status
Completed
Location
University of Alabama at Birmingham (UAB) - O'Neal Cancer Center
Start Date
2021-08-27
Trial ID
NCT04811027
Treatments Being Tested
This is a multicentre, multinational Phase Ib study in female HR+ MBC patie...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06
Trial ID
NCT04252768
Treatments Being Tested
The goal of this clinical trial is to compare the safety and efficacy of ef...
Status
Terminated
Location
The Oncology Institute
Start Date
2023-05-22
Trial ID
NCT05747794
Treatments Being Tested
The proposed Phase IIb clinical study aims to investigate the safety and ef...
Status
Completed
Location
AZ Sint-Jan Burgge-Oostende
Start Date
2015-12
Trial ID
NCT02614833
Treatments Being Tested
The purpose of this study is to compare eftilagimod alfa (efti) in combinat...
Status
Active Not Recruiting
Location
Norton Cancer Institute - Audubon
Start Date
2025-03-21
Trial ID
NCT06726265
The purpose of this study is to determine the safety, tolerability and reco...
Status
Completed
Location
Royal Brisbane Womens Hospital
Start Date
2016-04
Trial ID
NCT02676869
Treatments Being Tested
This phase I trial aims to investigate a potential enhancement of IMP321 im...
Status
Active Not Recruiting
Location
Helios Klinikum Bad Saarow
Start Date
2017-08-15
Trial ID
NCT03252938